Petter Brandal
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation Necrosis.
Journal: Neuro-oncology
Published: May 05, 2026
Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.
Journal: Clinical and translational radiation oncology
Published: May 03, 2026
Case Report: Proton beam therapy - friend or foe for patients with IDH-mutated WHO grade 2 and 3 gliomas?
Journal: Frontiers in oncology
Published: February 04, 2026
Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study.
Journal: Journal of neuro-oncology
Published: January 19, 2026
Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy.
Journal: Clinical and translational radiation oncology
Published: December 09, 2025
Unexpected frequency of radiation induced contrast enhancement after proton radiotherapy in glioma patients treated within the Swedish PRO-CNS study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 05, 2025
Spatial-temporal recurrence patterns of grade 4 glioma using deep learning integrated multiparametric MRI and molecular pathology.
Journal: NPJ precision oncology
Published: October 14, 2025
Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trial.
Journal: Neuro-oncology advances
Published: July 30, 2025
European neuro-oncology quality assessment (ENOQUA): A European organization for the research and treatment of cancer (EORTC) brain tumor group research project.
Journal: Neuro-oncology practice
Published: June 13, 2025
A scoping review of proton radiation therapy and mutant-isocitrate dehydrogenase-inhibitors in IDH mutated lower-grade gliomas: pushing beyond surrogate end-points.
Journal: Acta neurochirurgica
Published: May 30, 2025
Unveiling regional differences in glioblastoma patient survival with real-world data from the Norwegian brain tumor quality registry.
Journal: Journal of neuro-oncology
Published: May 06, 2025
Last Updated: 09/26/2026